Eusebio Manchado

4.0k total citations · 2 hit papers
24 papers, 2.9k citations indexed

About

Eusebio Manchado is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Eusebio Manchado has authored 24 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Eusebio Manchado's work include Microtubule and mitosis dynamics (8 papers), Cancer-related Molecular Pathways (6 papers) and Protein Degradation and Inhibitors (5 papers). Eusebio Manchado is often cited by papers focused on Microtubule and mitosis dynamics (8 papers), Cancer-related Molecular Pathways (6 papers) and Protein Degradation and Inhibitors (5 papers). Eusebio Manchado collaborates with scholars based in United States, Spain and Switzerland. Eusebio Manchado's co-authors include Marcos Malumbres, Scott W. Lowe, María Guillamot, Manuel Eguren, Elisa de Stanchina, Marta Cañamero, Irene García-Higuera, Sergio Moreno, Pierre Dubus and Juan Méndez and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Eusebio Manchado

24 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system

2014 468 citations Danilo Maddalo, Eusebio Manchado et al. Nature profile →
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling

2014 362 citations Susann Weissmueller, Eusebio Manchado et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eusebio Manchado United States	18	2.0k	1.1k	670	398	306	24	2.9k
François Lehembre Switzerland	17	1.8k 0.9×	1.1k 0.9×	391 0.6×	362 0.9×	252 0.8×	26	2.5k
Elena Díaz‐Rodríguez Spain	23	1.8k 0.9×	1.2k 1.1×	915 1.4×	412 1.0×	170 0.6×	45	2.8k
Qunyan Yu United States	12	1.9k 0.9×	1.7k 1.5×	652 1.0×	321 0.8×	222 0.7×	17	2.9k
Frank McCormick United States	16	2.6k 1.3×	902 0.8×	486 0.7×	339 0.9×	220 0.7×	29	3.3k
Ilya G. Serebriiskii United States	33	2.5k 1.2×	1.0k 0.9×	730 1.1×	488 1.2×	191 0.6×	97	3.8k
Natalia Jura United States	25	2.1k 1.0×	1.3k 1.1×	423 0.6×	248 0.6×	237 0.8×	50	3.2k
Peter Bouwman Netherlands	22	2.5k 1.2×	1.1k 1.0×	319 0.5×	400 1.0×	424 1.4×	42	3.4k
David Santamarı́a Spain	21	2.3k 1.1×	1.5k 1.3×	753 1.1×	452 1.1×	197 0.6×	43	3.3k
Fernando Calvo Spain	22	1.8k 0.9×	1.0k 0.9×	1.1k 1.6×	467 1.2×	336 1.1×	42	2.9k
Floris Foijer Netherlands	31	2.0k 1.0×	920 0.8×	1.1k 1.6×	802 2.0×	330 1.1×	87	2.9k

Countries citing papers authored by Eusebio Manchado

Since Specialization

Citations

This map shows the geographic impact of Eusebio Manchado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eusebio Manchado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eusebio Manchado more than expected).

Fields of papers citing papers by Eusebio Manchado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eusebio Manchado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eusebio Manchado. The network helps show where Eusebio Manchado may publish in the future.

Co-authorship network of co-authors of Eusebio Manchado

This figure shows the co-authorship network connecting the top 25 collaborators of Eusebio Manchado. A scholar is included among the top collaborators of Eusebio Manchado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eusebio Manchado. Eusebio Manchado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Chun‐Hao, Yan Yan, Rohit Thummalapalli, et al.. (2023). Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma. Cancer Discovery. 14(2). 308–325. 21 indexed citations

Arbour, Kathryn C., Eusebio Manchado, Matthew J. Bott, et al.. (2021). Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations. JTO Clinical and Research Reports. 3(1). 100256–100256. 9 indexed citations

Lu, Hengyu, Chen Liu, Roberto Velazquez, et al.. (2019). SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors. Molecular Cancer Therapeutics. 18(7). 1323–1334. 58 indexed citations

Lu, Hengyu, Chen Liu, Roberto Velazquez, et al.. (2019). Abstract 954: SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS mutant tumors treated with MEK inhibitors. 954–954. 1 indexed citations

Ruscetti, Marcus, Josef Leibold, Matthew J. Bott, et al.. (2018). NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 362(6421). 1416–1422. 268 indexed citations

O’Rourke, Kevin P., Evangelia Loizou, Geulah Livshits, et al.. (2017). Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer. Nature Biotechnology. 35(6). 577–582. 173 indexed citations

Álvarez‐Fernández, Mónica, María Salazar‐Roa, David Partida, et al.. (2017). Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer. Cell Death and Differentiation. 25(5). 828–840. 73 indexed citations

Fraile, Julia M., Eusebio Manchado, Amaia Lujambio, et al.. (2017). USP39 Deubiquitinase Is Essential for KRAS Oncogene-driven Cancer. Journal of Biological Chemistry. 292(10). 4164–4175. 37 indexed citations

Brea, Elliott J., Claire Y. Oh, Eusebio Manchado, et al.. (2016). Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells. Cancer Immunology Research. 4(11). 936–947. 128 indexed citations

10.

Manchado, Eusebio, Chun‐Hao Huang, Nilgun Tasdemir, et al.. (2016). A Pipeline for Drug Target Identification and Validation. Cold Spring Harbor Symposia on Quantitative Biology. 81. 257–267. 14 indexed citations

11.

Weissmueller, Susann, Eusebio Manchado, Michael Saborowski, et al.. (2014). Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling. Cell. 157(2). 382–394. 362 indexed citations breakdown →

12.

Dow, Lukas E., Zeina Nasr, Michael Saborowski, et al.. (2014). Conditional Reverse Tet-Transactivator Mouse Strains for the Efficient Induction of TRE-Regulated Transgenes in Mice. PLoS ONE. 9(4). e95236–e95236. 62 indexed citations

13.

Maddalo, Danilo, Eusebio Manchado, Carla P. Concepcion, et al.. (2014). In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature. 516(7531). 423–427. 468 indexed citations breakdown →

14.

Eguren, Manuel, Eva Porlan, Eusebio Manchado, et al.. (2013). The APC/C cofactor Cdh1 prevents replicative stress and p53-dependent cell death in neural progenitors. Nature Communications. 4(1). 2880–2880. 48 indexed citations

15.

Weissmueller, Susann, Michael Saborowski, Eusebio Manchado, Vishal Thapar, & Scott W. Lowe. (2013). Abstract C54: Pdgfrb is an essential mediator of p53(mut)-driven metastasis in pancreatic cancer. Cancer Research. 73(19_Supplement). C54–C54. 1 indexed citations

16.

Manchado, Eusebio, María Guillamot, & Marcos Malumbres. (2012). Killing cells by targeting mitosis. Cell Death and Differentiation. 19(3). 369–377. 182 indexed citations

17.

Eguren, Manuel, Eusebio Manchado, & Marcos Malumbres. (2011). Non-mitotic functions of the Anaphase-Promoting Complex. Seminars in Cell and Developmental Biology. 22(6). 572–578. 62 indexed citations

18.

Guillamot, María, Eusebio Manchado, Massimo Chiesa, et al.. (2011). Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription. Scientific Reports. 1(1). 189–189. 34 indexed citations

19.

Manchado, Eusebio, María Guillamot, Guillermo de Cárcer, et al.. (2010). Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ Phosphatase. Cancer Cell. 18(6). 641–654. 169 indexed citations

20.

García-Higuera, Irene, Eusebio Manchado, Pierre Dubus, et al.. (2008). Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nature Cell Biology. 10(7). 802–811. 297 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact